Option chain shows key data for Journey Medical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Journey Medical.

Journey Medical (NASDAQ:DERM) Stock, Option Chain

Journey Medical

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

A Different Picture

News

Movers

DERM

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.

What&#39;s Going On With Journey Medical Stock Today?

AGRI

AILE

BCDA

CELH

CLEU

CMLS

CRWD

EFSH

ENSV

ESPR

FCEL

GERN

GMGI

HOUS

HOVR

ICCH

LENZ

MLGO

NISN

NVAX

OPRA

PERI

PRST

RENB

ROMA

SBFM

SIFY

SKYE

SMHI

SPEC

SYNX

TELL

THAR

TNXP

TPHS

VRAX

WETH

WLDS

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Long Ideas

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying

Journey Medical Corporation - Common Stock

Journey Medical Corp

DermTech Inc

DermTech Inc Warrants(20/06/2022)

Dermapharm Holding SE

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics Inc

Dermisonics Inc

Press Releases

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Health Care

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

SWK Holdings Provides Portfolio Update

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

General

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Earnings

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

BTCY

CKPT

ELUT

ETON

FBIO

FBIOP

SWKH

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

ALT5 Sigma

Alto Neuroscience

Assertio Holdings

Bioage Labs

Biote

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

Ikena Oncology

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

Nektar Therapeutics

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Nutriband

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Cassava Sciences

scPharmaceuticals

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Third Harmonic Bio

Veru

Ventyx Biosciences

Zhengye Biotechnology Holding Limited - Ordinary Shares

Zhengye Biotechnology

Lake Street

Rodman & Renshaw

Roth MKM

Alliance Global Partners

B. Riley Securities

Comments

Journey Medical

Journey Medical (DERM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga